Group 4 Created with Sketch.
Your changes have been saved

Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE in Uterine Fibroids

Share
station description Health Professional radio gives you access to interesting and entertaining intervie... read more
Health Professional Radio - Podcast
Duration: 11:12
Dr. Juan Camilo Arjona Ferreira, Chief Medical Officer of Myovant Sciences discusses uterine fibroids and the recent FDA approval of MYFEMBREE® for the treatment of heavy menstrual bleeding associated with uterine fibroids. MYFEMBREE is also being studied in endometriosis.
#MyovantSciences #MYFEMBR
Snippets are a new way to share audio!
You can clip a small part of any file to share, add to playlist, and transcribe automatically. Just click the to create your snippet!
Snippets: Clips of Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE in Uterine Fibroids that people like
There are currently no snippets from Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE in Uterine Fibroids.
Snippets are an easy way to highlight your favorite soundbite from any piece of audio and share with friends, or make a trailer for Health Professional Radio - Podcast
Playlists that Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE in Uterine Fibroids appears on.
There are currently no playlists containing this audio.
Add this audio track to one of your playlists
Add to Playlist
Up Next
Full Description
Back to Top
Dr. Juan Camilo Arjona Ferreira, Chief Medical Officer of Myovant Sciences discusses uterine fibroids and the recent FDA approval of MYFEMBREE® for the treatment of heavy menstrual bleeding associated with uterine fibroids. MYFEMBREE is also being studied in endometriosis.
#MyovantSciences #MYFEMBREE
Juan Camilo Arjona Ferreira, MD, Chief Medical Officer of Myovant Sciences. Dr. Arjona Ferreira was previously Senior Vice President, Clinical Development at Shionogi. At Shionogi, Dr. Arjona Ferreira was responsible for leading the company’s U.S. Clinical Development organization and he served on the company’s U.S. Senior Leadership Team and the Global Scientific Committee. Prior to joining Shionogi, Dr. Arjona Ferreira spent over a decade at Merck & Co. where he was Executive Director of Clinical Research in Women’s Health. At Merck, he chaired the product development teams for all programs in contraception and women’s health. Dr. Arjona Ferreira earned his MD and completed his postgraduate specialist training in Obstetrics and Gynecology at Colegio Mayor del Rosario in Bogota, Colombia.
Up Next
Add to playlist
New playlist

Embed

COPY
Embed Options
Create Playlist
Select the Station you want to upload this audio to
Station
0 / 140
0 / 2000
Playlist Icon Image:
(.jpg, .png, min size 500x500px)
Privacy
Subscribers
Your
voice
matters.
Discover & Listen to the world’s largest free collection of audio
Password reset

Enter your email address that you used to register. We'll send you an email with your username and a link to reset your password.



If you still need help, contact Vurbl Support
Password reset sent

You have been sent instructions on resetting you password to the email associated with your account. Please check your email and signing in again.


Back to Sign In
If you still need help, contact Vurbl Support
Your
voice
matters.
Discover & Listen to the world’s largest free collection of audio
Reset password

Please enter your new password below.



If you still need help, contact Vurbl Support
Your voice matters.
Discover & Listen to the world’s largest free collection of audio
Verify Email

Enter your email address that you used to register. We'll send you an email with a link to verify your email.



Cancel
Delete Profile
Are you sure? We will miss you :'(
Delete
Delete Audio
Are you sure?
Delete
Delete Playlist
Are you sure you want to delete this playlist?
Delete
Notifications Mark all as read
    You currently have no notifications
    Edit Snippet
    0 / 140
    0 / 140